Tags
Language
Tags
May 2024
Su Mo Tu We Th Fr Sa
28 29 30 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 1

Pharmaceutical Biotechnology: A Focus on Industrial Application

Posted By: yoyoloit
Pharmaceutical Biotechnology: A Focus on Industrial Application

Pharmaceutical Biotechnology; A Focus on Industrial Application
by Adalberto Pessoa Jr.

English | 2021 | ISBN: 1032013745 | 401 pages | True PDF | 31.15 MB

Natural Polymers for Pharmaceutical Applications: Volume 2: Marine- and Microbiologically Derived Polymers

Posted By: sasha82
Natural Polymers for Pharmaceutical Applications: Volume 2: Marine- and Microbiologically Derived Polymers

Natural Polymers for Pharmaceutical Applications: Volume 2: Marine- and Microbiologically Derived Polymers by Amit Kumar Nayak, Md Saquib Hasnain, Dilipkumar Pal
2019 | ISBN: 1771888466 | English | 218 pages | PDF | 23 MB

Natural Polymers for Pharmaceutical Applications: Volume 3: Animal-Derived Polymers

Posted By: sasha82
Natural Polymers for Pharmaceutical Applications: Volume 3: Animal-Derived Polymers

Natural Polymers for Pharmaceutical Applications: Volume 3: Animal-Derived Polymers by Amit Kumar Nayak, Md Saquib Hasnai, Dilipkumar Pal
2019 | ISBN: 1771888474 | English | 196 pages | PDF | 14 MB

Current Applications of Pharmaceutical Biotechnology

Posted By: AvaxGenius
Current Applications of Pharmaceutical Biotechnology

Current Applications of Pharmaceutical Biotechnology by Ana Catarina Silva
English | EPUB | 2020 | 406 Pages | ISBN : 3030404633 | 19.93 MB

This book offers an authoritative review of biopharmaceuticals and their clinical relevance. Biopharmaceuticals have been showing high therapeutic potential by means of biological and biosimilar medicines, particularly for the treatment of cancer, chronic diseases (e.g. diabetes, Crohn's disease, psoriasis and rheumatoid arthritis), neurodegenerative disorders (e.g. multiple sclerosis), and they have also been contributing to the progress of innovative therapies such as assisted reproductive medicine. Since the eighties, several biopharmaceuticals have been approved and, due to patents expiration, many biosimilars are also marketed.